ScholarIQanswers from OpenAlex & ORCID
Genichiro Ishii
ResearcherPublications, citations & collaboration network
Genichiro Ishii is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Genichiro Ishii have?
ScholarIQindexed works
Genichiro Ishii has 490 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Genichiro Ishii have?
ScholarIQcitation count
Genichiro Ishii has 15,107 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Genichiro Ishii?
ScholarIQh-index
Genichiro Ishii has an h-index of 67 in OpenAlex.
What is the i10-index of Genichiro Ishii?
ScholarIQi10-index
Genichiro Ishii has an i10-index of 199 in OpenAlex.
What is the ORCID of Genichiro Ishii?
ScholarIQorcid
The ORCID for Genichiro Ishii is on the source record.
What is the OpenAlex record for Genichiro Ishii?
ScholarIQopenalex
The OpenAlex for Genichiro Ishii is on the source record.
What are the most-cited papers on Genichiro Ishii?
ScholarIQmost cited works
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Shogo Kumagai, Shohei Koyama, Kota Itahashi, Tokiyoshi Tanegashima, Yi-Tzu Lin, Yosuke Togashi, Takahiro Kamada, Takuma Irie, Genki Okumura, Hidetoshi Kono, Daisuke Ito, Rika Fujii, Sho Watanabe, Atsuo Sai, Shota Fukuoka, Eri Sugiyama, Go Watanabe, Takuya Owari, Hitomi Nishinakamura, Daisuke Sugiyama, Yuka Maeda, Akihito Kawazoe, Hiroki Yukami, Keigo Chida, Yuuki Ohara, Tatsuya Yoshida, Yuki Shinno, Yuki Takeyasu, Masayuki Shirasawa, Kenta Nakama, Keiju Aokage, Jun Suzuki, Genichiro Ishii, Takeshi Kuwata, Naoya Sakamoto, Masahito Kawazu, Toshihide Ueno, Taisuke Mori, Naoya Yamazaki, Masahiro Tsuboi, Yasushi Yatabe, Takahiro Kinoshita, Toshihiko Doi, Kohei Shitara, Hiroyuki Mano, Hiroyoshi Nishikawa
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, Eri Sugiyama, Hitomi Nishinakamura, Yoshiko Takeuchi, Vitaly Kochin, Kota Itahashi, Yuka Maeda, Shigeyuki Matsui, Takuma Shibahara, Yasuho Yamashita, Takuma Irie, Ayaka Tsuge, Shota Fukuoka, Akihito Kawazoe, Hibiki Udagawa, Keisuke Kirita, Keiju Aokage, Genichiro Ishii, Takeshi Kuwata, Kenta Nakama, Masahito Kawazu, Toshihide Ueno, Naoya Yamazaki, Kōichi Goto, Masahiro Tsuboi, Hiroyuki Mano, Toshihiko Doi, Kohei Shitara, Hiroyoshi Nishikawa
Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment
Genichiro Ishii, Atsushi Ochiai, Shinya Neri
Predominant infiltration of macrophages and CD8<sup>+</sup> T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Osamu Kawai, Genichiro Ishii, Kaoru Kubota, Yukinori Murata, Yoichi Naito, Tetsuya Mizuno, Keiju Aokage, Nagahiro Saijo, Yutaka Nishiwaki, Akihiko Gemma, Syoji Kudoh, Atsushi Ochiai
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
Kiyotaka Yoh, Takashi Seto, Miyako Satouchi, Makoto Nishio, Noboru Yamamoto, Haruyasu Murakami, Naoyuki Nogami, Shingo Matsumoto, Takashi Kohno, Koji Tsuta, Katsuya Tsuchihara, Genichiro Ishii, Shogo Nomura, Akihiro Sato, Atsushi Ohtsu, Yuichiro Ohe, Kōichi Goto